Cargando…

Prognostic significance of the CRP/Alb and neutrophil to lymphocyte ratios in hepatocellular carcinoma patients undergoing TACE and RFA

BACKGROUND: The C‐reactive protein (CRP)/albumin (Alb) ratio (CAR) is a basic inflammatory factor that has been related to poor survival of patients with various tumors. Our research retrospectively examined the relationship between the CAR and the prognosis of hepatocellular carcinoma (HCC). METHOD...

Descripción completa

Detalles Bibliográficos
Autores principales:	Shen, Yanjun, Wang, Huige, Li, Wendong, Chen, Jinglong
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2019
Materias:	Research Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6868405/ https://www.ncbi.nlm.nih.gov/pubmed/31418936 http://dx.doi.org/10.1002/jcla.22999

Ejemplares similares

Prognostic significance of lymphocyte-to-monocyte ratio and platelet-to-lymphocyte ratio in patients with hepatocellular carcinoma undergoing transcatheter arterial chemoembolization and radiofrequency ablation
por: Shen, Yanjun, et al.
Publicado: (2019)

A Novel Neutrophil-to-Lymphocyte Ratio and Sarcopenia Based TACE-Predict Model of Hepatocellular Carcinoma Patients
por: Wang, Shangyuan, et al.
Publicado: (2023)

Prognostic Role of Neutrophil-to-Lymphocyte Ratio (NLR), Lymphocyte-to-Monocyte Ratio (LMR), Platelet-to-Lymphocyte Ratio (PLR) and Lymphocyte-to-C Reactive Protein Ratio (LCR) in Patients with Hepatocellular Carcinoma (HCC) undergoing Chemoembolizations (TACE) of the Liver: The Unexplored Corner Linking Tumor Microenvironment, Biomarkers and Interventional Radiology
por: Minici, Roberto, et al.
Publicado: (2022)

Prognostic significance of neutrophil-lymphocyte ratio in hepatocellular carcinoma: a meta-analysis
por: Xiao, Wei-Kai, et al.
Publicado: (2014)

Prognostic Significance of the Neutrophil-Lymphocyte Ratio and Platelet-Lymphocyte Ratio in Neuroendocrine Carcinoma
por: Kim, Hyeon-Jong, et al.
Publicado: (2022)

Laparoscopic RFA with splenectomy for hepatocellular carcinoma
por: Hu, Kunpeng, et al.
Publicado: (2016)

Clinical Significance of Peripheral Blood Lymphocyte Subtypes and Cytokines in Patients with Hepatocellular Carcinoma Treated with TACE
por: Wang, Hongyu, et al.
Publicado: (2022)

Prognostic significance of preoperative neutrophil-to-lymphocyte ratio and platelet-to-lymphocyte ratio in patients with glioma
por: Wang, Junli, et al.
Publicado: (2018)

Prognostic Significance of Neutrophil to Lymphocyte Ratio, Lymphocyte to Monocyte Ratio, and Platelet to Lymphocyte Ratio in Patients with Nasopharyngeal Carcinoma
por: Lu, Aiying, et al.
Publicado: (2017)

The prognostic and diagnostic significance of the neutrophil-to-lymphocyte ratio in hepatocellular carcinoma: a prospective controlled study
por: Johnson, Philip J., et al.
Publicado: (2021)

Neutrophil-to-Lymphocyte Ratio and Early Tumor Shrinkage as Predictive Biomarkers in Unresectable Hepatocellular Carcinoma Patients Treated With Lenvatinib, PD-1 Inhibitors, in Combination With TACE
por: Qu, Shuping, et al.
Publicado: (2023)

Radiofrequency Ablation (RFA) Combined with Transcatheter Arterial Chemoembolization (TACE) for Patients with Medium-to-Large Hepatocellular Carcinoma: A Retrospective Analysis of Long-Term Outcome
por: Liu, Weiwen, et al.
Publicado: (2020)

Evaluation of the Association of Sleep Apnea-Related Systemic Inflammation with CRP, ESR, and Neutrophil-to-Lymphocyte Ratio
por: Korkmaz, Mukadder, et al.
Publicado: (2015)

The prognostic significance of the neutrophil-to-lymphocyte ratio and the platelet-to-lymphocyte ratio in giant cell tumor of the extremities
por: Chen, Zhenhao, et al.
Publicado: (2019)

Neutrophil-to-Lymphocyte, Lymphocyte-to-Monocyte, and Platelet-to-Lymphocyte Ratios: Prognostic Significance in COVID-19
por: BG, Shivakumar, et al.
Publicado: (2021)

Prognostic significance of the neutrophil-to-lymphocyte ratio with distal cholangiocarcinoma patients
por: Ji, Fengming, et al.
Publicado: (2020)

Prognostic Significance of Preoperative Neutrophil-to-Lymphocyte Ratio in Patients With Meningiomas
por: Kuranari, Yuki, et al.
Publicado: (2020)

Neutrophil-to-lymphocyte ratio in malignant pleural fluid: Prognostic significance
por: Popowicz, Natalia, et al.
Publicado: (2021)

A multicenter prospective study of TACE combined with lenvatinib and camrelizumab for hepatocellular carcinoma with portal vein tumor thrombus
por: Li, Xiaomi, et al.
Publicado: (2023)

The lymphocyte-C-reactive protein ratio as the optimal inflammation-based score in patients with hepatocellular carcinoma underwent TACE
por: Lu, Liang-He, et al.
Publicado: (2021)

Clinical and prognostic significance of preoperative lymphocyte-monocyte ratio, neutrophil-lymphocyte ratio and neutrophil-monocyte ratio on esophageal squamous cell carcinoma patients
por: Shang, Qi-Xin, et al.
Publicado: (2020)

Relationships of the neutrophil–lymphocyte and CRP–albumin ratios with the duration of hospitalization and fatality in geriatric patients with COVID-19
por: Kalyon, Semih, et al.
Publicado: (2021)

Combined use of CRP with neutrophil-to-lymphocyte ratio in differentiating between infectious and noninfectious inflammation in hemodialysis patients
por: Beberashvili, Ilia, et al.
Publicado: (2023)

Prognostic significance of neutrophil-to-lymphocyte ratio and platelet-to-lymphocyte ratio in non-small cell lung cancer
por: Bayraktaroglu, Mesut, et al.
Publicado: (2023)

Prediction of Local Tumor Progression after Radiofrequency Ablation (RFA) of Hepatocellular Carcinoma by Assessment of Ablative Margin Using Pre-RFA MRI and Post-RFA CT Registration
por: Yoon, Jeong Hee, et al.
Publicado: (2018)

Prognostic significance of the neutrophil-to-lymphocyte and platelet-to-lymphocyte ratio in patients with metastatic gastric cancer
por: Zhao, Guanghui, et al.
Publicado: (2020)

Albertson (Alb) spectral radii and Albertson (Alb) energies of graph operation
por: Munir, Muhammad Mobeen, et al.
Publicado: (2023)

The prognostic significance of neutrophil-to-lymphocyte ratio at different time points in patients with hepatocellular carcinoma receiving liver resection
por: Dai, Tianxing, et al.
Publicado: (2020)

Downstaging and Conversation Strategy for Advanced Hepatocellular Carcinoma with Portal Vein Branch Tumor Thrombus: TACE, (125)I Seed Implantation, and RFA for Hepatocellular Carcinoma with Portal Vein Branch Tumor Thrombus
por: Zhao, Xiao-Hui, et al.
Publicado: (2023)

Prognostic and clinicopathological significance of neutrophil-to-lymphocyte ratio in patients with oral cancer
por: Yang, Yun, et al.
Publicado: (2018)

Prognostic significance of neutrophil-to-lymphocyte ratio in esophageal squamous cell carcinoma
por: Sakin, Aysegul, et al.
Publicado: (2021)

Prognostic significance of preoperative neutrophil-to-lymphocyte ratio in surgically resected schwannomas
por: Takahara, Kento, et al.
Publicado: (2023)

TACE versus TACE + entecavir versus TACE + tenofovir in the treatment of HBV associated hepatocellular carcinoma
por: Lu, Haohao, et al.
Publicado: (2023)

Prognostic significance of the neutrophil-to-lymphocyte ratio and platelet-to-lymphocyte ratio in patients with stage III and IV colorectal cancer
por: Kim, Jae Hyun, et al.
Publicado: (2017)

Pretreatment neutrophil–lymphocyte ratio: useful prognostic biomarker in hepatocellular carcinoma
por: Najjar, Marc, et al.
Publicado: (2018)

A New Perspective for Predicting the Therapeutic Success of RFA in Solid BTNs: Quantitative Initial RFA Ratio by Contrast-Enhanced Ultrasound
por: Zhu, Yaqiong, et al.
Publicado: (2022)

LDH, CRP and ALB predict nucleic acid turn negative within 14 days in symptomatic patients with COVID-19
por: Liu, Gaoli, et al.
Publicado: (2021)

Prognostic significance of the neutrophil/lymphocyte ratio in patients undergoing treatment with nivolumab for recurrent non-small-cell lung cancer
por: Rapoport, Bernardo L, et al.
Publicado: (2020)

Prognostic significance of neutrophil-to-lymphocyte ratio in middle thoracic esophageal squamous cell carcinoma patients undergoing radical esophagectomy
por: Hu, Jia, et al.
Publicado: (2020)

The neutrophil-to-lymphocyte ratio is a predictive factor for the survival of patients with hepatocellular carcinoma undergoing transarterial chemoembolization
por: Wang, Chengguo, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_u9lpe1pn4v84jvttgeg6av518j